Stock Events

Stock Events

BioMark Diagnostics 

$0.3358
2
+$0.01+2.07%Tuesday 18:12

Statistics

Day High
0.3358
Day Low
0.3358
52W High
0.5044
52W Low
0.2259
Volume
200
Avg. Volume
1,921
Mkt Cap
35.76M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Sep 30Expected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0.01
-0
-0
-0
Expected EPS
N/A
Actual EPS
-0.0019

Financials

-2,445.7%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
43,831.82Revenue
-1.07MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap23.99B
Guardant Health focuses on liquid biopsies and cancer diagnostics, directly competing in BioMark's market of early cancer detection.
Fulgent Genetics
FLGT
Mkt Cap567.37M
Fulgent Genetics offers extensive genetic testing, which is crucial for personalized cancer therapies, overlapping with BioMark's diagnostic solutions.
Illumina
ILMN
Mkt Cap35.63B
Illumina provides genomic sequencing solutions that are foundational to cancer research and diagnostics, impacting the same market as BioMark.
Qiagen NV
QGEN
Mkt Cap9.24B
Pacific Biosciences of California
PACB
Mkt Cap809.71M
Pacific Biosciences offers sequencing systems that aid in understanding cancer genetics, competing in the broader diagnostics market.
Bionano Genomics
BNGO
Mkt Cap16.07M
Bionano Genomics focuses on genomic analysis, including cancer research, which aligns with BioMark's focus on diagnostic solutions.
Myriad Genetics
MYGN
Mkt Cap434.25M
Myriad Genetics specializes in molecular diagnostic tests that include cancer screenings, directly competing with BioMark's offerings.

About

BioMark Diagnostics Inc. is an oncology-focused firm that develops sophisticated diagnostic tools for cancer. These solutions are designed to aid in the identification of the disease, its ongoing monitoring, and the assessment of initial therapeutic interventions. The company has a research partnership with the Icahn School of Medicine, under which they conduct clinical studies concentrating on the early detection of lung cancer. Established in 2014, BioMark Diagnostics Inc. has its main office in Richmond, Canada, and functions as a subsidiary of Biomark Technologies Inc.
Show More
CEO
Rashid Ahmed Maula Bux
Employees
9
Country
Canada
ISIN
CA09073K1084
WKN
000A12EKB

Listings

STU
DE
20B.STU
OTC Link
US
BMKDF
F
DE
20B.F
CN
CA
BUX.CN

0 Comments

Share your thoughts

FAQs

What is BioMark Diagnostics stock price today?▼
The current price of BMKDF is $0.34 USD — it has increased by +2.07% in the past 24 hours. Watch BioMark Diagnostics stock price performance more closely on the chart.
What is BioMark Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange BioMark Diagnostics stocks are traded under the ticker BMKDF.
Is BioMark Diagnostics stock price growing?▼
BMKDF stock has risen by +2.07% compared to the previous week, the month change is a -12.97% fall, over the last year BioMark Diagnostics has showed a +39.88% increase.
What is BioMark Diagnostics market cap?▼
Today BioMark Diagnostics has the market capitalization of 35.76M
What were BioMark Diagnostics earnings last quarter?▼
BMKDF earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is BioMark Diagnostics revenue for the last year?▼
BioMark Diagnostics revenue for the last year amounts to 43,831.82 USD.
What is BioMark Diagnostics net income for the last year?▼
BMKDF net income for the last year is -1.07M USD.
How many employees does BioMark Diagnostics have?▼
As of November 2, 2026, the company has 9 employees.
In which sector is BioMark Diagnostics located?▼
BioMark Diagnostics operates in the Health & Wellness sector.
When did BioMark Diagnostics complete a stock split?▼
BioMark Diagnostics has not had any recent stock splits.
Where is BioMark Diagnostics headquartered?▼
BioMark Diagnostics is headquartered in Richmond, Canada.